Fluvoxamine
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Fluvoxamine and local guidelines before prescribing.
SSRI
Mechanism
SSRI and strong CYP1A2 inhibitor.
Uses
OCD, depression.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Nausea, somnolence, insomnia, tremor.
Interactions
Raises clozapine, theophylline, tizanidine, warfarin and ropinirole levels; MAOIs.
Contraindications and cautions
Mania
Monitoring
Sodium
Pregnancy and breastfeeding
Avoid unless essential
Renal and hepatic impairment
Reduce dose in hepatic impairment
Overdose and reversal
Supportive
Special advice
Check interacting drugs; taper on stopping.
More from the textbook: uses, cautions and other points
- Tizanidine - alpha-2 agonist; drowsiness, hypotension , dry mouth, liver toxicity (LFTs); contraindicated with fluvoxamine and ciprofloxacin (CYP1A2 - large rise in levels).
Neurology: Anatomy, Physiology and Pharmacology - Erythromycin, ciprofloxacin, fluvoxamine raise levels; carbamazepine (avoid - agranulocytosis) lowers them.
Psychiatry: Psychosis and schizophrenia - Metabolised by CYP1A2 - levels raised by ciprofloxacin , clarithromycin , erythromycin, fluvoxamine, cimetidine, heart failure, liver disease, viral infection, stopping smoking; lowered by smoking , rifampicin, carbamazepine, phenytoin, alcohol.
Respiratory: Anatomy, Physiology and Pharmacology - Baclofen / tizanidine | Spasticity; baclofen - never stop suddenly; tizanidine - not with ciprofloxacin or fluvoxamine.
Neurology: Anatomy, Physiology and Pharmacology - Enzyme inhibitors - amiodarone , fluconazole and miconazole (including oral gel ), metronidazole , clarithromycin and erythromycin, ciprofloxacin , co-trimoxazole , allopurinol, cimetidine, SSRIs (fluoxetine, fluvoxamine).
Haematology: Anatomy Physiology and Pharmacology - SSRI (fluoxetine, sertraline, escitalopram, paroxetine, fluvoxamine) - often higher doses and longer (12 weeks) before response; continue at least 12 months if effective.
Psychiatry: Anxiety, stress and somatic disorders
Where it is discussed in the book
- Respiratory: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (2 mentions)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Psychiatry: Anxiety, stress and somatic disorders (1 mention)
- Psychiatry: Psychosis and schizophrenia (1 mention)